WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H328703
CAS#: 50293-90-8 (HCl)
Description: Levosalbutamol Hydrochloride, also known as (R)-albuterol, is a β2-adrenergic receptor (β-AR) agonist used to treat asthma and chronic obstructive pulmonary disease.
Hodoodo Cat#: H328703
Name: Levosalbutamol Hydrochloride
CAS#: 50293-90-8 (HCl)
Chemical Formula: C13H22ClNO3
Exact Mass: 0.00
Molecular Weight: 275.773
Elemental Analysis: C, 56.62; H, 8.04; Cl, 12.85; N, 5.08; O, 17.40
Related CAS #: 50293-90-8(HCl) 34391-04-3(free base),
Synonym: Levosalbutamol Hydrochloride; Xopenex; (R)-albuterol; R-albuterol; R albuterol
IUPAC/Chemical Name: (R)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hydrochloride
InChi Key: OWNWYCOLFIFTLK-YDALLXLXSA-N
InChi Code: InChI=1S/C13H21NO3.ClH/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-6,12,14-17H,7-8H2,1-3H3;1H/t12-;/m0./s1
SMILES Code: O[C@@H](CNC(C)(C)C)C1=CC=C(O)C(CO)=C1.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info: Related CAS# 34391-04-3 (Levosalbutamol) 50293-90-8 (Levosalbutamol Hydrochloride)
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 275.77 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Brunetti L, Poiani G, Dhanaliwala F, Poppiti K, Kang H, Suh DC. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma. Am J Health Syst Pharm. 2015 Jun 15;72(12):1026-35. doi: 10.2146/ajhp140551. PubMed PMID: 26025994.
2: Yuan J, Lu ZK, Zhang Y, Wu J, Love BL, Schulz RM. Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid population. Pediatr Pulmonol. 2016 Oct 4. doi: 10.1002/ppul.23565. PubMed PMID: 27701831.
3: Arroyo MG, Couëtil LL, Nogradi N, Kamarudin MM, Ivester KM. Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction. J Vet Intern Med. 2016 Jul;30(4):1333-7. doi: 10.1111/jvim.14320. Epub 2016 Jun 9. PubMed PMID: 27282625.
4: New drug overview. Levalbuterol hydrochloride. Am J Health Syst Pharm. 1999 Jun 15;56(12):1191. PubMed PMID: 10484651.
5: Handley DA, Morley J, Vaickus L. Levalbuterol hydrochloride. Expert Opin Investig Drugs. 1998 Dec;7(12):2027-41. PubMed PMID: 15991945.
6: Slattery D, Wong SW, Colin AA. Levalbuterol hydrochloride. Pediatr Pulmonol. 2002 Feb;33(2):151-7. Review. PubMed PMID: 11802253.
7: Kelly A, Kennedy A, John BM, Duane B, Lemanowicz J, Little J. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients. Ann Pharmacother. 2013 May;47(5):644-50. doi: 10.1345/aph.1S003. Epub 2013 Apr 23. PubMed PMID: 23613097.
8: Jat KR, Khairwa A. Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis. Pulm Pharmacol Ther. 2013 Apr;26(2):239-48. doi: 10.1016/j.pupt.2012.11.003. Epub 2012 Nov 30. Review. PubMed PMID: 23207739.
9: Raffay T, Kc P, Reynolds J, Di Fiore J, MacFarlane P, Martin RJ. Repeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model. Neonatology. 2014;106(2):126-32. doi: 10.1159/000362684. Epub 2014 Jun 20. PubMed PMID: 24969536; PubMed Central PMCID: PMC4134388.
10: Broski SE, Amundson DE. Paradoxical response to levalbuterol. J Am Osteopath Assoc. 2008 Apr;108(4):211-3. Erratum in: J Am Osteopath Assoc.2008 May;108(5): 266. PubMed PMID: 18443029.
11: Randall MJ, Kostin SF, Burgess EJ, Hoyt LR, Ather JL, Lundblad LK, Poynter ME. Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells. Front Endocrinol (Lausanne). 2015 Jan 12;5:236. doi: 10.3389/fendo.2014.00236. eCollection 2014. PubMed PMID: 25628603; PubMed Central PMCID: PMC4290686.
12: Pagán Rivera BL, Anselmi FJ, Torres Mdel M, Segarra A, Rivera JR. Usefulness Of Glucocorticoids In The Management Of Foreign Body Aspiration. Bol Asoc Med P R. 2015 Jul-Sep;107(3):24-7. Review. PubMed PMID: 26742192.
13: Yuan J, Lu K. Economic Impact of Levalbuterol Versus Albuterol in Low-Income Population. Value Health. 2014 Nov;17(7):A781. doi: 10.1016/j.jval.2014.08.376. Epub 2014 Oct 26. PubMed PMID: 27202897.
14: Hardasmalani MD, DeBari V, Bithoney WG, Gold N. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care. 2005 Jul;21(7):415-9. PubMed PMID: 16027572.
15: Bio LL, Willey VJ, Poon CY. Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children. J Pediatr Pharmacol Ther. 2011 Jul;16(3):191-8. doi: 10.5863/1551-6776-16.3.191. PubMed PMID: 22479161; PubMed Central PMCID: PMC3292530.
